Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Roche resubmits NDA for Xenical

Nov. 17, 1997

New guidelines for patients exposed to fenfluramine or dexfenfluramine

Nov. 17, 1997

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

Nov. 17, 1997

Novo Nordisk files for HRT product in U.S.

Nov. 13, 1997

Alendronate and etidronate prevent steroid-induced osteoporosis

Nov. 13, 1997

ACAT inhibitors described by Sankyo in patent literature

Nov. 13, 1997

Palatin obtains rights to new ED diagnostic/therapeutic

Nov. 12, 1997

P&U's Genotropin approved by FDA for adult growth hormone deficiency

Nov. 12, 1997

FDA clears new indication for Zocor

Nov. 11, 1997

Orphan Medical receives approvable letter from FDA for Sucraid

Nov. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...